← Back to Search

Voice Analysis Technology for Heart Attack Recovery

N/A
Recruiting
Led By Amir Lerman, MD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
Actively treated for an anxiety or depressive disorder through psychotherapy or pharmacologic treatments
Mania diagnosis
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 12 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial will test whether a smartphone app that detects anxiety and depression can improve outcomes for people undergoing cardiac rehabilitation.

Who is the study for?
This trial is for heart attack survivors who own a smartphone, can use an app, and speak English. They must be diagnosed with myocardial infarction (MI) and starting cardiac rehab within 4 weeks of hospital discharge. It's not for pregnant individuals or those actively treated for anxiety or depression, nor patients with cardiac transplants, active substance use, neurocognitive disorders, psychosis, or mania.
What is being tested?
The study tests if a voice analysis app on smartphones can help detect and manage depression and anxiety when used alongside traditional cardiac rehabilitation programs to improve patient outcomes compared to just the rehabilitation program alone.
What are the potential side effects?
Since this intervention involves using a smartphone application for voice analysis rather than medication or invasive procedures, there are no direct medical side effects associated with its use in the context of this clinical trial.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am currently receiving treatment for anxiety or depression.
Select...
I have been diagnosed with mania.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 12 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in anxiety symptoms
Change in depressive symptoms
Change in health behaviors
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Cardiac rehabilitation plus voice analysisExperimental Treatment1 Intervention
Subjects will complete 12 weeks of cardiac rehabilitation as per clinical care and utilize a voice analysis smartphone app.
Group II: Cardiac rehabilitation onlyActive Control1 Intervention
Subjects will complete 12 weeks of cardiac rehabilitation as per clinical care.

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,362 Previous Clinical Trials
3,065,761 Total Patients Enrolled
Amir Lerman, MDPrincipal InvestigatorMayo Clinic
18 Previous Clinical Trials
2,523 Total Patients Enrolled

Media Library

Ellipsis Health Voice Application Clinical Trial Eligibility Overview. Trial Name: NCT05371470 — N/A
Heart Attack Research Study Groups: Cardiac rehabilitation plus voice analysis, Cardiac rehabilitation only
Heart Attack Clinical Trial 2023: Ellipsis Health Voice Application Highlights & Side Effects. Trial Name: NCT05371470 — N/A
Ellipsis Health Voice Application 2023 Treatment Timeline for Medical Study. Trial Name: NCT05371470 — N/A
~75 spots leftby Oct 2025